The boss of AstraZeneca has said the group takes the probe in China that saw the detention of its president in the country “very seriously” as the drugs giant hiked its financial outlook once again.
AstraZeneca’s shares have been sent reeling after it emerged that Chinese authorities had deepened their investigation into the business.
